Self-Replicating RNA Viruses for RNA Therapeutics

Area of Science:

• Virology
• Immunotherapy
• Gene Therapy

Background:

• Self-replicating single-stranded RNA viruses offer efficient gene delivery and expression for therapeutic applications.
• Viral vectors based on alphaviruses, flaviviruses, measles viruses, and rhabdoviruses are being explored for novel treatments.

Purpose of the Study:

• To review the achievements of self-replicating RNA viruses in RNA therapy.
• To summarize findings from preclinical animal studies and human clinical trials.

Main Methods:

• Review of preclinical studies in animal tumor models.
• Analysis of clinical trial data for various indications, including vaccines and cancer immunotherapy.
• Examination of viral vector platforms such as alphaviruses and rhabdoviruses.

Main Results:

• Preclinical studies show viral vectors can induce antibody responses against tumors and pathogens.
• Clinical trials demonstrate safety and immunogenicity of alphavirus and rhabdovirus vectors.
• Successful outcomes in Phase I, II, and III trials for vaccines and infectious disease treatments.

Conclusions:

• Self-replicating RNA viruses are effective platforms for RNA therapy, vaccine development, and immunotherapy.
• Ongoing clinical trials highlight the therapeutic potential and safety of these viral vectors.
• Further research and application of these viral systems are warranted for diverse medical needs.